Date:10/5/2011

pierce and puncture the skin as 'barbaric.' and tell their health care providers that they 'hate metal skin staples.'  In addition, traumatic metal skin staples require removal which is costly, inconvenient and can be painful.  The primary advantage of metal skin staples is speed of closure – reducing anesthesia and operating room time compared to absorbable suturing.  With the introduction of the INSORB Absorbable Skin Stapler in 2005, there is now a rapid closure technology that does not create additional injury to the patient.  Although there are some circumstances when metal skin staples may be clinically justifiable, we believe any skin closure method that pierces and punctures the skin – literally creating additional injury – is obsolete for the closure of routine surgical incisions.  Furthermore, in the more patient-centric 21st century environment, the use of traumatic metal skin staples, without first informing the patient of clinically-effective alternatives and gaining patient consent, is a clear violation of the Universal Patient's Bill of Rights."

"We measure the success of our practice by the satisfaction of our patients and our commitment to continually improve and evolve," said K. Anthony Shibley, M.D., F.A.C.O.G., Obstetrics & Gynecology Specialists, P.A., Edina, MN. (www.obgynpa.com)  "Given the improved skin closure technologies available today, I can no longer justify the use of metal skin staples for typical skin closure of surgical incisions.  Metal skin staples do cause additional injury and discomfort to the patient, and require removal.  My patients prefer absorbable skin closure methods that do not cause additional injury citing increased comfort and appearance."

"Our objectives in launching this national campaign with the new ihatemetalskinstaples.com website are to 1)  educate patients of their rights to b
'/>"/>

SOURCE Incisive Surgical, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Incisive Surgical Issued Notice of Allowance for Key Absorbable Skin Stapler Patent
2. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
3. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
4. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
5. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
6. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
7. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
8. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
9. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
10. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
11. Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination